BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piredda R, Desmarais P, Masellis M, Gasca‐salas C. Cognitive and psychiatric symptoms in genetically determined Parkinson’s disease: a systematic review. Eur J Neurol 2019;27:229-34. [DOI: 10.1111/ene.14115] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Trinh J, Schymanski EL, Smajic S, Kasten M, Sammler E, Grünewald A. Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s disease. Medizinische Genetik 2022;34:103-116. [DOI: 10.1515/medgen-2022-2127] [Reference Citation Analysis]
2 Nguyen TT, Kim YJ, Lai TT, Nguyen PT, Koh YH, Nguyen LTN, Ma HI, Kim YE. PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy. J Parkinsons Dis 2022;12:1201-17. [PMID: 35253778 DOI: 10.3233/JPD-213065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Prange S, Klinger H, Laurencin C, Danaila T, Thobois S. Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment. Drugs Aging 2022;39:417-39. [PMID: 35705848 DOI: 10.1007/s40266-022-00942-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pinizzotto CC, Dreyer KM, Aje OA, Caffrey RM, Madhira K, Kritzer MF. Spontaneous object exploration in a recessive gene knockout model of Parkinson’s disease: Development and progression of object recognition memory deficits in male Pink1-/- rats.. [DOI: 10.1101/2022.05.23.493123] [Reference Citation Analysis]
5 Vela-desojo L, Urso D, Osuna-lópez M, Hoenicka J. Non-Motor Symptoms in PLA2G6-Associated Dystonia-Parkinsonism: A Case Report and Literature Review. JCM 2022;11:1590. [DOI: 10.3390/jcm11061590] [Reference Citation Analysis]
6 Senkevich K, Alcalay RN, Gan-or Z. Genetics of Non-Motor Symptoms of Parkinson’s Disease. Non-Motor Parkinson's Disease 2022. [DOI: 10.1017/9781009039291.019] [Reference Citation Analysis]
7 Tönges L, Kwon EH, Klebe S. Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers. Front Aging Neurosci 2022;14:822949. [DOI: 10.3389/fnagi.2022.822949] [Reference Citation Analysis]
8 Yu Z, Liu G, Li Y, Arkin E, Zheng Y, Feng T. Erythrocytic α-Synuclein Species for Parkinson’s Disease Diagnosis and the Correlations With Clinical Characteristics. Front Aging Neurosci 2022;14:827493. [DOI: 10.3389/fnagi.2022.827493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hussein A, Tielemans A, Baxter MG, Benson DL, Huntley GW. Cognitive Deficits and Altered Cholinergic Innervation in Young Adult Mice Carrying a Parkinson’s Disease LRRK2-G2019S Knockin Mutation.. [DOI: 10.1101/2022.01.26.477929] [Reference Citation Analysis]
10 Cuzzolaro M, Melchionda N. Parkinson’s Disease and Eating and Weight Disorders. Hidden and Lesser-known Disordered Eating Behaviors in Medical and Psychiatric Conditions 2022. [DOI: 10.1007/978-3-030-81174-7_31] [Reference Citation Analysis]
11 Soman SK, Dagda RK. Role of Cleaved PINK1 in Neuronal Development, Synaptogenesis, and Plasticity: Implications for Parkinson's Disease. Front Neurosci 2021;15:769331. [PMID: 34795558 DOI: 10.3389/fnins.2021.769331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vizziello M, Borellini L, Franco G, Ardolino G. Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson's Disease. Cells 2021;10:3022. [PMID: 34831247 DOI: 10.3390/cells10113022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Senkevich K, Rudakou U, Gan-Or Z. New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin. Neuropharmacology 2021;202:108822. [PMID: 34626666 DOI: 10.1016/j.neuropharm.2021.108822] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
14 Tripathi A, Scaini G, Barichello T, Quevedo J, Pillai A. Mitophagy in depression: Pathophysiology and treatment targets. Mitochondrion 2021;61:1-10. [PMID: 34478906 DOI: 10.1016/j.mito.2021.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Schejter-Margalit T, Kizony R, Shirvan J, Cedarbaum JM, Bregman N, Thaler A, Giladi N, Mirelman A. Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease. Parkinsonism Relat Disord 2021;90:84-9. [PMID: 34416663 DOI: 10.1016/j.parkreldis.2021.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Lizama BN, Chu CT. Neuronal autophagy and mitophagy in Parkinson's disease. Mol Aspects Med 2021;:100972. [PMID: 34130867 DOI: 10.1016/j.mam.2021.100972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
17 Gonzalez-Latapi P, Bayram E, Litvan I, Marras C. Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors. Behav Sci (Basel) 2021;11:74. [PMID: 34068064 DOI: 10.3390/bs11050074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
18 Hussein A, Guevara CA, Del Valle P, Gupta S, Benson DL, Huntley GW. Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction. Neuroscientist 2021;:10738584211011979. [PMID: 33966533 DOI: 10.1177/10738584211011979] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
19 Kasap M, Dwyer DS. Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease. J Neural Transm (Vienna) 2021;128:749-62. [PMID: 33961117 DOI: 10.1007/s00702-021-02348-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
20 Senkevich KA, Kopytova AE, Usenko TS, Emelyanov AK, Pchelina SN. Parkinson's Disease Associated with GBA Gene Mutations: Molecular Aspects and Potential Treatment Approaches. Acta Naturae 2021;13:70-8. [PMID: 34377557 DOI: 10.32607/actanaturae.11031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sosero YL, Yu E, Krohn L, Rudakou U, Mufti K, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Fahn S, Waters C, Sardi SP, Bandres-Ciga S, Alcalay RN, Gan-Or Z, Senkevich K. LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's disease. Neurobiol Aging 2021;103:142.e1-5. [PMID: 33781610 DOI: 10.1016/j.neurobiolaging.2021.02.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
22 Liu X, Le W. Profiling Non-motor Symptoms in Monogenic Parkinson's Disease. Front Aging Neurosci 2020;12:591183. [PMID: 33192488 DOI: 10.3389/fnagi.2020.591183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
23 Sosero YL, Yu E, Krohn L, Rudakou U, Mufti K, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Fahn S, Waters C, Sardi SP, Bandres-ciga S, Alcalay RN, Gan-or Z, Senkevich K, International Parkinson Disease Genomics Consortium (IPDGC). LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease.. [DOI: 10.1101/2020.09.23.20197558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Painous C, Marti MJ. <p>Cognitive Impairment in Parkinson’s Disease: What We Know so Far</p>. JPRLS 2020;Volume 10:7-17. [DOI: 10.2147/jprls.s263041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Xu X, Xiong S, Zhou X, Chen X, Wang X, Liang C, Yin J, Luo X, Fu J, Wen X, Ning F, Gu S, Zhu X, Ma G, Chen Y, Li Y, Wang Y. SAP97 polymorphisms associated with early onset Parkinson’s disease. Neuroscience Letters 2020;728:134931. [DOI: 10.1016/j.neulet.2020.134931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Redfern C, Mason SL, Barker RA, Coles A. Parkinson's disease and spirituality. NeuroRehabilitation 2020;46:31-9. [PMID: 32039874 DOI: 10.3233/NRE-192947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]